Continuation of clozapine during chemotherapy and a stem cell transplant
Cancer incidence rates in the UK have increased by more than a third over the last four decades, so the likelihood of requiring concurrent chemotherapy and clozapine is increasing. In this situation clinicians are faced with a clinical conundrum: to stop clozapine and risk a psychotic relapse, or to continue clozapine and risk a potentially fatal agranulocytosis. This case report describes how a multidisciplinary team (MDT) worked together to balance the mental and physical health needs of a patient.
Source: Progress in Neurology and Psychiatry - Category: Neurology Authors: Amy Burlingham, Padmini Anandakumar, Lisa Brownell Tags: Case notes Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Chemotherapy | Health | Men | Neurology | Psychiatry | Stem Cell Therapy | Stem Cells | Transplants